文献速递造血干细胞移植与细胞治疗

组织学分级与急性移植物抗宿主病治疗反应及结局的相关性

The association of histologic grade with acute graft-versus-host disease response and outcomes.
PubMed 文献 · Am J Hematol · 2017-05-26

该研究纳入2005至2013年接受异基因造血细胞移植的503例患者,识别出231例患者的300次皮肤和胃肠道活检事件。皮肤(R=0.32)和胃肠道(R=0.61)组织学分级均与临床分级相关(P<0.001)。多因素分析显示组织学分级(HR 0.87,P=0.011)和临床分级(HR 0.86,P=0.008)与第28天治疗反应显著相关,组织学分级低于对应临床分级预示更好的反应(HR 1.26,P=0.027),而组织学分级高于对应临床分级与反应无关(P=0.89)。

要点

  • 皮肤和胃肠道组织学分级均与急性GVHD临床分级相关。
  • 组织学分级低于对应临床分级预示第28天治疗反应更好(HR 1.26)。
  • 组织学分级高于对应临床分级与治疗反应无关(P=0.89)。

核心结论

  • 组织学GVHD分级与临床分级和治疗反应相关,可能有助于进一步预测急性GVHD的严重程度和治疗反应。

研究设计与样本

  • 研究纳入2005至2013年接受异基因造血细胞移植的503例患者,识别出231例患者的300次皮肤和胃肠道活检事件。

主要发现

  • 皮肤(R=0.32)和胃肠道(R=0.61)组织学分级均与临床分级相关(P<0.001)。
  • 多因素分析显示组织学分级(HR 0.87,P=0.011)和临床分级(HR 0.86,P=0.008)与第28天治疗反应显著相关。
  • 组织学分级低于对应临床分级预示更好的反应(HR 1.26,P=0.027),而组织学分级高于对应临床分级与反应无关(P=0.89)。
  • 临床分级和非复发死亡率显著相关(HR 1.47,P=0.04),组织学分级和非复发死亡率显著相关(HR 1.67,P=0.002)。
  • 临床分级和全因死亡率显著相关(HR 1.57,P=0.001),组织学分级和全因死亡率显著相关(HR 1.29,P=0.046)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Consensus criteria are routinely used to clinically grade acute graft-versus-host disease (GVHD). A histologic grading system for acute GVHD is available, but there are limited data on its correlation with clinical grade and hematopoietic cell transplantation (HCT) outcomes. Among 503 patients who underwent allogeneic HCT from 2005 to 2013, we identified 300 biopsy episodes of the skin and gastrointestinal (GI) tract in 231 patients. Histologic grade was correlated with clinical grade of GVHD, day 28 treatment response, and outcome. Both skin (R = 0.32) and GI (R = 0.61) histologic grade correlated with clinical grade (P < 0.001). On multivariable analysis, histologic grade (HR 0.87, P = 0.011) and clinical grade (HR 0.86, P = 0.008) were significantly associated with day 28-treatment response. A histologic grade lower than its associated clinical grade predicted for better response (HR 1.26, P = 0.027), while a histologic grade higher than associated clinical grade had no correlation with response (P = 0.89). Both clinical and histologic GVHD grade were significant predictors of non-relapse mortality (HR 1.47, P = 0.04 and HR 1.67, P = 0.002, respectively) and all-cause mortality (HR 1.57, P = 0.001 and HR 1.29, P = 0.046, respectively). Histologic GVHD grade thus is correlated with clinical grading and treatment response, and may play a role in further predicting severity and treatment response of acute GVHD.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Narkhede M, Rybicki L, Abounader D, et al. The association of histologic grade with acute graft-versus-host disease response and outcomes. Am J Hematol. 2017. PMID: 28376566. doi:10.1002/ajh.24749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。